Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
显示 2021 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Sarclisa | Sanofi aventis Deutschland GmbH | Concentrate for solution for infusion | Jan 1, 2021 | Biological |
| Oramorph | L. Molteni & C dei F. LLi Alitti Societa di Esercizio | Oral solution | Jan 1, 2021 | NCE |
| BALVERSA | JANSSEN-CILAG SPA | Film-coated tablet | Jan 1, 2021 | NCE |
| BALVERSA | JANSSEN-CILAG SPA | Film-coated tablet | Jan 1, 2021 | NCE |
| Milrinone BOS | Gland Pharma Limited | Solution for injection | Jan 1, 2021 | NCE |
| BALVERSA | JANSSEN-CILAG SPA | Film-coated tablet | Jan 1, 2021 | NCE |
| Rotavex Solution | (Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd | Solution | Jan 1, 2021 | Generic |
| Xaliptine | Fareva Unterach GmbH | Concentrate for solution for infusion | Jan 1, 2021 | Generic |
| Ketorolac BOS | Gland Pharma Limited | Injection | Jan 1, 2021 | NCE |
| PHENYLEPHRINE | LABORATOIRE AGUETTANT | Solution for injection in pre-filled syringe | Jan 1, 2021 | NCE |
| Lectra | LABORATORIOS ALCALA FARMA | Powder for solution for infusion | Jan 1, 2021 | Generic |
| CO-Ribex | SOTHEMA | Film-coated tablet | Jan 1, 2021 | Generic |
| Dextrose 4.3 % in 0.18 % Sodium Chloride | Pharmaceutical Solution Industries (PSI) | Solution for infusion | Jan 1, 2021 | Generic |
| CO-Ribex | SOTHEMA | Film-coated tablet | Jan 1, 2021 | Generic |
| Xaliptine | Fareva Unterach GmbH | Concentrate for solution for infusion | Jan 1, 2021 | Generic |
| Enoxaparin BOS | Gland Pharma Limited | Solution for injection | Jan 1, 2021 | Biological |
| CO-Ribex | SOTHEMA | Film-coated tablet | Jan 1, 2021 | Generic |
| Ribex | SOTHEMA | Film-coated tablet | Jan 1, 2021 | Generic |
| Enoxaparin BOS | Gland Pharma Limited | Solution for injection | Jan 1, 2021 | Biological |
| CONTRAVE | PATHEON INC | Prolonged-release tablet | Jan 1, 2021 | NCE |
